ClinicalTrials.gg
RecruitingNCT07036640Updated Jun 25, 2025

The Impact of Acute Exercise in the Heat on Breast Milk Production and Composition in Lactating Women

An interventional study of Heat exposure in Lactation, sponsored by Providence College. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-25.

Sponsored by Providence College · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 251 studies in Breast Feeding with a site in United States — 43 open to participants now, 49 under way, none of them phase 3. Breast Feeding · United States.

Planned enrollment
174th of 202
10 · median 83
Started
2025
with 15 others
No phase
164 of 251
26 open now
Primary completion
2026-05
later than 8 of 48 live
Registered
234th of 251
by date

Among the 251 studies in Breast Feeding with a site in United States, this one is the 174th largest by planned enrollment of the 202 interventional ones that give a count, is one of 16 that started in 2025, is one of 164 with no phase, reaches primary completion later than 8 of the 48 other live ones, and was the 234th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

43 of the 251 studies in Breast Feeding with a site in United States are open now. Recruiting first, the newest first:

37 more — sign in →

All 43 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 18 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 251 studies in Breast Feeding with a site in United States, or all of them as a file.
02

Study summary

This clinical trial aims to determine whether heat stress alters 24-hour breast milk production and composition following an acute bout of exercise in the heat among lactating women.

The main questions are:

  1. To ascertain whether heat stress alters 24-hour breast milk production following acute exercise in the heat among lactating women. We hypothesize that breast milk production will decrease to a greater extent following acute exercise in the heat compared to acute exercise with no heat stress. Lactating mothers will complete an acute exercise bout at 40% of their peak oxygen consumption (VO2peak) for 60 mins in a hot (36 °C, 40% relative humidity) and thermoneutral environment (20 °C, 20% relative humidity). Participants will record their total breast milk production in a 24-hour period using an infant scale.
  2. to discover whether heat stress impacts the energy composition of breast milk following acute exercise in the heat among lactating women. We hypothesize that energy density will decrease to a greater extent following acute exercise in the heat compared to acute exercise with no heat stress. Participants will use a manual expression breast pump to collect 10 mL of breast milk from each breast immediately and 24 hours post-exercise. Energy density (lactose, protein, and lipid content) will be assessed via enzyme-linked immunosorbent assays.

Participants will complete the following visits: 1) initial consent visit 2) baseline testing; 3) acute exercise in the hot condition (HOT; 36C, 40% relative humidity), and 4) acute exercise in the temperate, thermoneutral condition (TEMP; 20C, 20% relative humidity). The baseline testing day will measure participant anthropometrics including height, weight, and body composition measured by a DEXA scan. For both experimental trials, participants will be asked to walk on a treadmill at based on their metabolic heat production (8W/kg) for 60 minutes. Heart rate (HR), mean skin temperature (Tsk), core temperature (Tcore), sweat loss (SL), and fluid intake will be measured throughout the exercise protocol. Breast milk composition will be measured through milk expression using a manual expression breast pump immediately and 24 hours post-exercise. Participants will log their breast milk production for 24 hours following the exercise using an infant scale to measure their infants before and after each feed.

Read the detailed description

This study will be a randomized, cross-over design with four study visits: 1) an initial visit where the participant can see the study equipment, ask questions, and fill out a brief questionnaire to determine whether they are eligible to participant; 2) baseline and metabolic heat production testing; 3) acute exercise in the hot condition [experimental trial 1 (HOT): 36C, 40% relative humidity], and 4) acute exercise in the temperate, thermoneutral condition [experimental trial 2 (TEMP): 20C, 20% relative humidity]. Data collection will occur at the Health and Human Performance Laboratory (HHPL) in the Department of Health Sciences.

Visit 1: Initial Visit The participant will come to the lab for an initial visit. During this brief visit (\<30 min), the participant can ask questions about the study, see the study equipment, and will be asked to complete a questionnaire to determine their eligibility.

Visit 2 (Baseline and Metabolic Heat Production Testing):

The baseline testing will collect participant anthropometric data, which includes height, body mass, and body composition (dual-energy X-ray absorptiometry, DXA) scan and a stepwise metabolic heat production test. Participants will report to the laboratory having abstained from caffeine, alcohol, and food (12, 24, and 4 hours, respectively). Upon arrival, participants will provide a small urine sample in a sterile urine cup to measure hydration status and for a pregnancy test. Researchers will measure hydration status using a refractometer. If the pregnancy test is positive, the PI will inform the participant that the test is positive and will not perform the scan. The participant will also no longer be eligible to continue with the study. After hydration assessment, nude body mass and height will be collected and the participant's body composition will measured using DXA. To obtain a nude body mass, a private curtain-changing area with a body weight scale will be provided to ensure privacy. Only the participant will be able to enter. The scale reading will come outside the private curtain area for the researchers to see. The DXA software will generate lean mass, fat mass, and body fat percentage. To calculate exercise intensity based on a fixed metabolic heat production (per unit body mass), participants will undergo a 24-min incremental treadmill test in an environmental chamber. Participants will perform the test in the same environmental conditions as the HOT trial (36C, 40% relative humidity; described below). Participants will don a heart rate (HR) monitor before testing. The treadmill test will consist of 6 x 4-min stages and progressively increase speed (2.5mph, 3.0mph, 3.5mph, 4.0mph, 4.5mph, and 5.0mph). The treadmill grade will be set at 2% to account for terrain and wind resistance. Oxygen consumption and respiratory exchange were collected continuously (30-sec average) using a Hans Rudolph metabolic mask (Hans Rudolph Inc., Shawnee, KS, USA) attached to a hose and delivered to the metabolic cart system (Parvo Medics Truemax 2400 Metabolic Measurement System, Consentius Technologies, Sandy, UT). These variables will be used to calculate metabolic heat production using partitional calorimetry (Cramer \& Jay, 2019). An exercise intensity of 8 W/kg was selected to elicit a brisk walking intensity. The metabolic heat production test is a standard procedure used in the thermal physiology literature to perform an unbiased comparison of thermoregulatory responses between groups (Jay \& Cramer 2015).

Visit 3 and 4: Experimental Trials (HOT \& TEMP). Experimental trials (HOT and TEMP) will consist of a 60 min treadmill exercise protocol at a fixed metabolic heat production per unit body mass (8 W/kg). Exercise will be performed in an environmental chamber. HR, mean skin temperature (Tsk), core temperature (Tcore), sweat loss, and fluid intake will be measured throughout the exercise protocol. Breast milk composition will be measured through milk expression using a manual expression breast pump 24-hour before (post exercise), one hour-post exercise and 24 hours post-exercise. Breastmilk samples will not be collected at the laboratory. Participants will be asked to collect samples at home and will be provided written instructions on the breastmilk collection procedure (described below). Participants will log their breast milk production for 24 hours before and after the exercise protocol using a supplied infant scale.

Over 24 hr before the start of exercise, participants will be provided with a water bottle to track their fluid intake, Tcore pill, food log, an infant scale, breastmilk production log, manual breastmilk expression pump, storage bag, and small cooler bag for transport. Participants will log their food and fluid intake during the day before, during, and after each experimental trial (24 hr before and after). Participants will be asked to maintain similar dietary habits during either experimental session. Participants will also be given an ingestible pill thermistor for Tcore assessment and asked to consume one pill approximately 6 hours before the start of exercise. Twenty-four hours before the start of the trial, participants will be asked to manually express 5 mL of breast milk immediately before the infant is put on the breast and 5 mL immediately after the infant has finished suckling. Participants who only express breastmilk will collect 5 mL from the start and end of their breastmilk expression session. This will collect fore and hind breast milk samples to account for different lipid concentrations between milk types. The fore and hind breastmilk samples will be analyzed separately and entered into a formula to estimate energy density [2,3] Breastmilk samples will be stored in the breastmilk storage bag provided. Participants will be asked to store the breast milk in their refrigerator and use the provided cooler bag to transport breastmilk when arriving for their visit. Participants will be asked to log breastmilk production by weighing infants (test weighing) or the quantity of expressed breast milk (see weighing infant protocol below).

On the experimental trial days, participants will report to the laboratory in the morning. Hydration status will be assessed through urine-specific gravity, urine color assessment, and body mass changes. If the core temperature pill passes before visit, the participant will have the option to use a core temperature pill as a suppository or re-schedule their trial. The pill will be given to you at your initial visit. Participants will be asked to wear an HR monitor and four skin temperature sensors placed on their chest, shoulder, thigh, and calf to assess mean Tsk. Participants will enter the environmental chamber for the exercise protocol. Immediately upon entering the environmental chamber, participants will perform a seated 10-minute passive equilibration period. Participants will then walk briskly at 8 W/kg for 60 mins. During exercise, Tcore, Tsk, and HR will be continuously monitored. Fluid will not be permitted during exercise.

After completing the exercise protocol, participants will provide a urine sample for hydration assessment, and body mass will be measured. Participants will receive a water bottle to track their fluid intake, food log, an infant scale (Doran DS4500), breastmilk production log, manual breastmilk expression pump, storage bag, and small cooler bag for transport before leaving the laboratory. Participants will be asked to log breastmilk production by weighing infants (test weighing) or the quantity of expressed breast milk. To account for evaporative losses, participants will be asked to measure their infants immediately before (Wb), immediately after (Wa), and 20 min (We) after feeding [4]. One hour and 24 hours after the completion of the exercise, participants will be asked to provide breast milk samples. Participants will be asked to store the breast milk in their refridgerator and use the provided cooler bag to transport breastmilk when arriving for their last visit (Visit 3). Following Visit 3, researchers will ask participants to report to the laboratory with frozen breast milk storage and to return other supplies (i.e., infant scale, manual breastmilk expression pump).

When participants bring in their breastmilk samples, fat content within them will be assessed immediately using the Creamatocrit method (Miller et al. 2013). Three mL of each sample will be aliquoted into separate 1-mL creamatocrit collection tubes. Each 1-mL milk sample will be placed into a micro-capillary tube and centrifuged for 3-5 minutes around 10,000 rpm. The height of the fat layer and total milk column will be measured following centrifugation

The remaining breastmilk sample will be immediately frozen in -80C after collection [5].The protein content of breastmilk samples will be determined using a Pierce Modified Lowry Protein assay kit [5,6] and lactose content will be measured using a lactose colorimetric assay kit after data collection is complete [5,7].

References:

  1. Jay O, Cramer MN. A new approach for comparing thermoregulatory responses of subjects with different body sizes. Temperature (Austin). 2015 Feb 11;2(1):42-3. doi: 10.1080/23328940.2014.996093. PMID: 27227002; PMCID: PMC4843865.
  2. Miller EM, Aiello MO, Fujita M, Hinde K, Milligan L, Quinn EA. Field and laboratory methods in human milk research. Am J Hum Biol. 2013 Jan-Feb;25(1):1-11. doi: 10.1002/ajhb.22334. Epub 2012 Oct 29. Erratum in: Am J Hum Biol. 2013 May-Jun;25(3):442. PMID: 23109280.
  3. Saint L, Smith M, Hartmann PE. 1984. The yield and nutrient content of colostrum and milk of women from giving birth to one month post-partum. BMJ 52:87-95.
  4. Woodward DR, Cumming FJ. Do ambient temperature and humidity influence the breast-milk intake of babies? J Paediatr Child Health. 1990;26:347-50. doi: 10.1111/j.1440-1754.1990.tb02450.x
  5. Nommsen L, Lovelady C, Heinig M, et al. Determinants of energy, protein, lipid, and lactose concentrations in human milk during the first 12 mo of lactation: the DARLING Study. Am J Clin Nutr. 1991;53:457-65. doi: 10.1093/ajcn/53.2.457
  6. PierceTM Modified Lowry Protein Assay Kit. https://www.thermofisher.com/order/catalog/product (accessed 30 July 2024.
  7. Lactose Assay Kit (Colorimetric/Fluorometric) \| LSBio. https://www.lsbio.com/assaykits/lactose-assay-kit-colorimetric-fluorometric-ls-k289/289 (accessed 30 July 2024)
03

Conditions studied

  • Lactation

Keywords

  • Lactation
  • Exercise
  • Heat Stress
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently breastfeeding or pumping expressed breastmilk for their 6-week to 24-month infants
  • Aged 18-45 years old
  • Delivered their infants between 37-42 weeks of gestational age

Exclusion criteria

Exclusion Criteria:

  • Obsterical complications during pregnancy
  • multiple gestation
  • Chronic disease (i.e., diabetes, hypertension, metabolic disease)
  • Heat illnness in the last 3 month
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    Heat exposure

    Heat exposure in environmental chamber during exercise (60 mins)

    Other: Heat exposure

  • No intervention
    Thermoneutral Condition

    Thermoneutral temperature (non-heat exposure condition)

Interventions

  • OtherHeat exposure

    Heat exposure during exercise

06

What researchers measure

Primary outcomes

  1. Breastmilk Composition

    Breastmilk lipid, protein, and lactose content

    Time frame: Measured 24hr before exercise, one hour post-exercise, and 24hr post exercise for each condition

  2. Breastmilk Production

    Breastmilk production (lactation)

    Time frame: Collected 24-hour before exercise, 1-hour post-exercise, and 24-hour post-exercise

Secondary outcomes

  1. Core temperature

    Internal core body temperature

    Time frame: Collected every minute for 60 minutes during exercise

  2. Heart rate

    Heart rate

    Time frame: Collected every minute for 60 minutes during exercise

  3. Skin temperature

    Mean skin temperature

    Time frame: Collected every minute for 60 min during exercise

07

Study locations

1 of 1 sites recruiting
  • Providence College
    Providence, Rhode Island 02918, United States
    Recruiting
08

References and documents

Publications

  • Nommsen LA, Lovelady CA, Heinig MJ, Lonnerdal B, Dewey KG. Determinants of energy, protein, lipid, and lactose concentrations in human milk during the first 12 mo of lactation: the DARLING Study. Am J Clin Nutr. 1991 Feb;53(2):457-65. doi: 10.1093/ajcn/53.2.457. PubMed 1989413 ↗
  • Woodward DR, Cumming FJ. Do ambient temperature and humidity influence the breast-milk intake of babies? J Paediatr Child Health. 1990 Dec;26(6):347-50. doi: 10.1111/j.1440-1754.1990.tb02450.x. PubMed 2073422 ↗
  • Saint L, Smith M, Hartmann PE. The yield and nutrient content of colostrum and milk of women from giving birth to 1 month post-partum. Br J Nutr. 1984 Jul;52(1):87-95. doi: 10.1079/bjn19840074. PubMed 6743645 ↗
  • Miller EM, Aiello MO, Fujita M, Hinde K, Milligan L, Quinn EA. Field and laboratory methods in human milk research. Am J Hum Biol. 2013 Jan-Feb;25(1):1-11. doi: 10.1002/ajhb.22334. Epub 2012 Oct 29. PubMed 23109280 ↗

Individual participant data

Plan to share: Yes — Data to be shared upon request.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be shared following the completion of the study.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2025; primary completion for May 2026, 9 months later.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 9 months is below that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 16, 2025
First posted
Jun 25, 2025
StartEst.
Jul 10, 2025
Primary completionEst.
May 1, 2026
CompletionEst.
May 1, 2026
Last update
Jun 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07036640
Lead sponsor
Providence College
Responsible party
Margaret Morrissey (Assistant Professor, Providence College) — Principal investigator
First posted
Jun 25, 2025
Start date
Jul 10, 2025 (estimated)
Primary completion
May 1, 2026 (estimated)
Completion
May 1, 2026 (estimated)
Last update
Jun 25, 2025

Study contacts

Margaret C Morrissey-Basler, PhD
Contact
mmorri17@providence.edu
4018650219
Margaret C Morrissey-Basler, PhD
principal investigator · Providence College

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion